[-] Show simple item record

dc.contributor.authorBailey, Justineng
dc.contributor.authorCarter, Nakia Joyceeng
dc.date.issued2009eng
dc.description.abstractProbiotics and rifaximin (Xifaxan) have been shown to reduce total number of flatus episodes and associated discomfort. (Strength of Recommendation [SOR]: B, based on small randomized controlled trials [RCTs]). Oral alpha-galactosidase (Beano) has been shown to reduce volume of flatus associated with fermentable carbohydrates and high-fiber diets. (SOR: B, based on small RCTs). Oral bismuth subsalicylate (Pepto-Bismol) and odor-reducing external devices containing activated charcoal have shown benefit in reducing flatus-associated odor. (SOR: C, based on disease-oriented evidence). Evidence for oral activated charcoal and simethicone has been inconsistent and does not support their use. (SOR: B, based on multiple small RCTs).eng
dc.identifier.urihttp://hdl.handle.net/10355/3874eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2009 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesAmerican family physician, 79, no. 12 (June 2009): 1098+.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectflatuseng
dc.subjectprobioticseng
dc.subjectodor reductioneng
dc.subject.lcshFlatulence -- Treatmenteng
dc.subject.lcshCarbon, Activated -- Therapeutic useeng
dc.subject.lcshProbiotics -- Therapeutic useeng
dc.titleEffective Management of Flatulenceeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record